IgG allotypes and subclasses in Norwegian patients with multiple sclerosis. 2000

G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
Department of Neurology, Haukeland Hospital, University of Bergen, N-502, Bergen, Norway.

Multiple sclerosis (MS) is a multifactorial disease in which genetic and environmental factors apparently have a major influence on the susceptibility and course of the disease. In the present study we have investigated the genetic basis and subclass levels of IgG in MS. Hundred and thirty-six Norwegian patients with MS and 92 controls were genotyped for IgG allotypes of the GM and KM systems. IgG and IgG subclasses were quantified in sera from 115 MS patients and 20 controls. Neither GM nor KM allo-, haplo- or genotypes were significantly correlated with susceptibility, severity or course of the disease. The G1M (3) (3), G2M (23) (23) and G3M (5) (5) allotypes were significantly correlated with high serum levels of IgG3, whereas high IgG2 levels were correlated with G1M (3) (3) and G2M (23) (23) in both patients and controls. Serum levels of IgG subclasses were not significantly correlated with course or severity of the disease. The results indicate no major role for IgG allotypes or IgG subclass levels in the pathogenesis of MS.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007126 Immunoglobulin Allotypes Allelic variants of the immunoglobulin light chains (IMMUNOGLOBULIN LIGHT CHAINS) or heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) encoded by ALLELES of IMMUNOGLOBULIN GENES. Allotypes, Immunoglobulin,Allotypic Antibodies,Antibodies, Allotypic,Ig Allotypes,Allotype, Ig,Allotype, Immunoglobulin,Allotypes, Ig,Allotypic Antibody,Antibody, Allotypic,Ig Allotype,Immunoglobulin Allotype
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D020022 Genetic Predisposition to Disease A latent susceptibility to disease at the genetic level, which may be activated under certain conditions. Genetic Predisposition,Genetic Susceptibility,Predisposition, Genetic,Susceptibility, Genetic,Genetic Predispositions,Genetic Susceptibilities,Predispositions, Genetic,Susceptibilities, Genetic

Related Publications

G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
January 1988, Annals of the New York Academy of Sciences,
G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
March 1982, Scandinavian journal of immunology,
G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
January 2014, Frontiers in immunology,
G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
July 1990, Acta neurologica Scandinavica,
G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
January 1993, Neurologia i neurochirurgia polska,
G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
May 1996, European journal of neurology,
G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
October 1982, Immunology today,
G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
December 1983, Clinical and experimental immunology,
G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
January 1974, Humangenetik,
G Raknes, and J A Fernandes Filho, and J P Pandey, and K M Myhr, and E Ulvestad, and H Nyland, and C A Vedeler
October 1982, Journal of immunogenetics,
Copied contents to your clipboard!